Ensemble Therapeutics Corporation - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

Ensemble Therapeutics Corporation - Product Pipeline Review - 2016

Ensemble Therapeutics Corporation - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
Ensemble Therapeutics Corporation - Product Pipeline Review - 2016
Published Aug 10, 2016
30 pages — Published Aug 10, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Ensemble Therapeutics Corporation - Product Pipeline Review - 2016, provides an overview of the Ensemble Therapeutics Corporations pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ensemble Therapeutics Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Ensemble Therapeutics Corporation
- The report provides overview of Ensemble Therapeutics Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Ensemble Therapeutics Corporations pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Ensemble Therapeutics Corporations out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Ensemble Therapeutics Corporations strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Ensemble Therapeutics Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Ensemble Therapeutics Corporations pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive project

  
Source:
Document ID
GMDHC08111CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
Ensemble Therapeutics Corporation Snapshot51
  Ensemble Therapeutics Corporation Overview51
  Key Information51
  Key Facts51
Ensemble Therapeutics Corporation Research and Development Overview62
  Key Therapeutic Areas62
Ensemble Therapeutics Corporation Pipeline Review86
  Pipeline Products by Stage of Development81
  Pipeline Products Monotherapy91
  Pipeline Products Partnered Products101
    Partnered Products/Combination Treatment Modalities111
  Pipeline Products Out-Licensed Products121
    Out-Licensed Products/Combination Treatment Modalities131
Ensemble Therapeutics Corporation Pipeline Products Glance142
  Ensemble Therapeutics Corporation Early Stage Pipeline Products141
    Preclinical Products/Combination Treatment Modalities141
    Discovery Products/Combination Treatment Modalities151
Ensemble Therapeutics Corporation Drug Profiles167
  Small Molecules to Inhibit Cyclophilin A for Hepatitis B161
    Product Description161
    Mechanism of Action161
    R&D Progress161
  Small Molecules to Inhibit Cyclophilin D for Cardiovascular and Central Nervous System171
    Product Description171
    Mechanism of Action171
    R&D Progress171
  Small Molecules to Inhibit IAP for Oncology181
    Product Description181
    Mechanism of Action181
    R&D Progress181
  Small Molecules to Inhibit USP9X for Metastatic Cancer191
    Product Description191
    Mechanism of Action191
    R&D Progress191
  Small Molecules to Inhibit PCSK9 for Cardiovascular Disease201
    Product Description201
    Mechanism of Action201
    R&D Progress201
  Small Molecules to Inhibit USP28 for Oncology211
    Product Description211
    Mechanism of Action211
    R&D Progress211
  Small Molecules to Inhibit USP30 for Oncology and Parkinson's disease221
    Product Description221
    Mechanism of Action221
    R&D Progress221
Ensemble Therapeutics Corporation Pipeline Analysis234
  Ensemble Therapeutics Corporation Pipeline Products by Target231
  Ensemble Therapeutics Corporation Pipeline Products by Route of Administration241
  Ensemble Therapeutics Corporation Pipeline Products by Molecule Type251
  Ensemble Therapeutics Corporation Pipeline Products by Mechanism of Action261
Ensemble Therapeutics Corporation Dormant Projects271
Ensemble Therapeutics Corporation Locations And Subsidiaries281
  Head Office281
Appendix292
  Methodology291
  Coverage291
  Secondary Research291
  Primary Research291
  Expert Panel Validation291
  Contact Us291
  Disclaimer301

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Ensemble Therapeutics Corporation - Product Pipeline Review - 2016" Aug 10, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Ensemble-Therapeutics-Corporation-Product-Pipeline-Review-2016-2088-16365>
  
APA:
Global Markets Direct - Market Research. (2016). Ensemble Therapeutics Corporation - Product Pipeline Review - 2016 Aug 10, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Ensemble-Therapeutics-Corporation-Product-Pipeline-Review-2016-2088-16365>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.